This Journal has an Open Access Option
24 issues in 2010—two volumes per year!
Antioxidants & Redox Signaling provides “Instant Online” publication 72 hours after acceptance
Latest Impact Factor* is 6.190
* 2008 Journal Citation Reports® published by Thomson Reuters, 2009
Average time to first decision: 18 days
Average time to triage decision: 48 hours
Antioxidants & Redox Signaling is the leading journal dedicated to the understanding of reactive species as messenger molecules regulating signal transduction and gene expression. New research reveals free radicals, which have been known as damaging agents, are being used for therapeutic purposes. This journal uncovers the expanding world of redox-based therapeutics—genetic, pharmacological, and nutritional.
ARS features:
• ROS/RNS as messengers
• Oxidation-reduction (redox) dependent regulation of molecular cell biology
• Molecular basis of oxidant and antioxidant action
• Role of reactive species and antioxidants in human health, aging, and disease
The Journal provides:
• Articles authored by international experts at highly recognized laboratories
• An international editorial board
• Forums on emerging, thematic issues
• Full length comprehensive invited reviews
Latest Impact Factor* is 6.190
* 2008 Journal Citation Reports® published by Thomson Reuters, 2009
Indexed/Abstracted in:
MEDLINE; Current Contents®/Life Sciences; Science Citation Index Expanded; Science Citation Index®; Biochemistry & Biophysics Citation Index®; Biological Abstracts; BIOSIS Previews; Journal Citation Reports/Science Edition; EMBASE/Excerpta Medica; EMBiology; Scopus; Chemical Abstracts